About Us

"Welcome to Stanford Vascular and Endovascular Surgery. We are dedicated to the highest levels of patient care, professional education and clinical and translational research."

 

Ronald L. Dalman, MD, Chidester Professor and Division Chief of Vascular Surgery

The Division works continually to improve quality of life for patients with vascular diseases. We are privileged to work with an outstanding team of faculty and community vascular specialists, cardiologists and cardiac surgeons, radiologists, podiatrists, rehabilitation specialists, basic scientists, engineers and computer scientists. Our ongoing collaborations have promoted remarkable academic and clinical productivity involving new and dramatically improved techniques for the diagnosis and treatment of vascular disease, gaining the Division international recognition as a Vascular Center of Excellence.

The faculty is distinguished by expertise in many aspects of vascular disease management, but perhaps none more so than aortic aneurysm disease. Stanford Vascular Surgeons are recognized around the world as leaders in aortic aneurysm treatment and research.


Faculty Wellness

Dr. Dalman discusses “the epidemic” of burnout and how to effectively build a career in vascular surgery at the London Aortic Symposium 2018, where he gave a keynote lecture focusing on his advice for the future.


2019 Spectrum MedTech Pilot Grants: Request for Proposals

The Spectrum MedTech Pilot Program funds projects involving medical devices and mobile technologies used for (1) therapeutic applications and (2) device-based patient-specific (or POC) diagnostic applications. Projects must have the objective of translating discoveries into novel medtech products that address unmet medical needs. Emphasis will be placed on technologies that have the potential to advance rapidly into patient care through development by venture funded startups, licensing to established companies, or other pathways. Only projects involving Stanford-owned intellectual property will be considered.

Funding Amount: Up to $50,000 per year.

Eligibility: Open to Stanford faculty with PI eligibility (with UTL, MCL, NTLR faculty appointments.), Clinical Educator (CE) faculty, clinical instructors, instructors, graduate students and post-doctoral scholars (clinical and non-clinical) are required to include a PI-eligible faculty member as co-PI on the application.
 
Application Due: Wednesday, May 1st, 2019
 
Questions? Contact Program Manager Ashley Dunn, MPH at adunn2@stanford.edu
 
See Stanford Seed Funding for more information on how to apply.
 
 


Latest News

Dr. Leeper awareded the American Heart Association Established Investigator Award

Congratulations to Dr. Nicholas Leeper, Assistant Professor of Surgery and Medicine for receiving the Established Investigator Award (EIA) from the American Heart Association (AHA).  Per the AHA, this award is designed “to support mid-career investigators with unusual promise and established records of accomplishments”.   The Leeper lab plans to use this support to investigate emerging immunological aspects of atherosclerosis, with a focus on developing new translational therapies designed to suppress vascular inflammation.

SHC Medical Executive Committee

Dr. Venita Chandra has been elected to the Stanford Health Care Medical Executive Committee.   

Match Results

Shernaz Dossabhoy

University of Massachussets Medical School

Shaunak Adkar

Duke University School of Medicine

OUR PROGRAMS

Patient Care

We provide expert care for patients with complex aortic, arterial and venous disorders.

 

Education

ACGME-accredited Stanford Traditional Vascular Residency (5+2 yrs)

ACGME-accredited Stanford Integrated Vascular Residency (0+5 yrs)

Vascular Medicine Fellowship

Interesting Cases

Educational Seminars

Research

Basic, translational and applied research into all facets of vascular disease.